Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03047395
Brief Title: A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) (LIMMITLESS)

First Submitted : February 7, 2017
First Submitted that Met QC Criteria : February 7, 2017
First Posted : February 9, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : May 21, 2019
Last Update Posted : May 23, 2019